BLIMP-1 mediated regulation of CD8+ TIL
BLIMP-1 mediated regulation of CD8+ TIL
批准号:
8595301
负责人:
TIMOTHY N BULLOCK
金额:
$31.64万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-01-01 至 2017-12-31
关键词:
AcuteAntibodiesAntigensAutologousBloodCD8B1 geneCancer ControlCancer VaccinesCell physiologyCellsChronicCytotoxic T-LymphocytesDataDevelopmentDiagnostic Neoplasm StagingExhibitsFunctional disorderGoalsHumanIL2 geneImmunotherapyIndiumInfiltrationInterferonsInterventionLinkLymphocyteLymphocyte FunctionMediatingMemoryModelingMusNeoplasm TransplantationPRDM1 genePatientsPlayProductionRegulationRoleSensitivity and SpecificitySurfaceT-LymphocyteTranscription Repressor/CorepressorTumor AntigensTumor stageTumor-Infiltrating LymphocytesVirus Diseasesbasecancer immunotherapyclinically relevantcytokinedesignfunctional restorationfunctional statusgenome-widemalignant breast neoplasmmelanomaoutcome forecastpathogenpreventpromoterpublic health relevancereceptorreceptor expressionresponsetranscription factortumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The exquisite sensitivity and specificity of T cells for their targets offers considerable promise for the use of immunotherapy in cancer control. However, in many instances, T cells found within tumors are dysfunctional. A major cause for this dysfunctional state is the expression of inhibitory molecules. We have found that the expression of inhibitory molecules by both murine and human tumor infiltrating CD8+ cytotoxic T cells correlates strongly with the expression of the transcription factor BLIMP-1. In this application we show that tumor infiltrating CD8+ T cells over-express BLIMP-1 compared to CD8+ T cells responding to acute viral infection. We show that limiting BLIMP-1 expression in tumor infiltrating lymphocytes results in reduced inhibitory molecule expression and increased functional activity. Further, we show that BLIMP-1 expression controls CD8+ T cell function beyond the expression of inhibitory molecules. From these data, we propose to pursue studies that will define how BLIMP-1 expression is regulated in tumor infiltrating lymphocytes, and will determine how BLIMP-1 expression regulates tumor infiltrating lymphocyte function. The studies presented here will illuminate the mechanisms behind tumor infiltrating lymphocyte dysfunction, and will provide opportunities to develop interventions that either prevent dysfunction, or restore
activity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Focused Ultrasound Regimens that Synergize with Melanoma Immunotherapy
-
批准号:10186745
-
项目类别:
-
资助金额:$64.9万
-
财政年份:2020
-
负责人:TIMOTHY N BULLOCK
-
依托单位:
Focused Ultrasound Regimens that Synergize with Melanoma Immunotherapy
-
批准号:10032967
-
项目类别:
-
资助金额:$67.57万
-
财政年份:2020
-
负责人:TIMOTHY N BULLOCK
-
依托单位:
Focused Ultrasound Regimens that Synergize with Melanoma Immunotherapy
-
批准号:10377443
-
项目类别:
-
资助金额:$66.22万
-
财政年份:2020
-
负责人:TIMOTHY N BULLOCK
-
依托单位:
Focused Ultrasound Regimens that Synergize with Melanoma Immunotherapy
-
批准号:10615036
-
项目类别:
-
资助金额:$66.22万
-
财政年份:2020
-
负责人:TIMOTHY N BULLOCK
-
依托单位:
Leveraging MR-Guided Focused Ultrasound to Potentiate Immunotherapy for GBM
-
批准号:10020956
-
项目类别:
-
资助金额:$20.89万
-
财政年份:2019
-
负责人:TIMOTHY N BULLOCK
-
依托单位:
Immunotherapeutic Nanoparticle Delivery to Melanoma With MR-Guided Focused Ultrasound
-
批准号:8945980
-
项目类别:
-
资助金额:$53.73万
-
财政年份:2015
-
负责人:TIMOTHY N BULLOCK
-
依托单位:
Immunotherapeutic Nanoparticle Delivery to Melanoma With MR-Guided Focused Ultrasound
-
批准号:9267820
-
项目类别:
-
资助金额:$51.93万
-
财政年份:2015
-
负责人:TIMOTHY N BULLOCK
-
依托单位:
BLIMP-1 mediated regulation of CD8+ TIL
-
批准号:8844054
-
项目类别:
-
资助金额:$4.35万
-
财政年份:2014
-
负责人:TIMOTHY N BULLOCK
-
依托单位:
BLIMP-1 mediated regulation of CD8+ TIL
-
批准号:8439016
-
项目类别:
-
资助金额:$30.6万
-
财政年份:2013
-
负责人:TIMOTHY N BULLOCK
-
依托单位:
BLIMP-1 mediated regulation of CD8+ TIL
-
批准号:8777888
-
项目类别:
-
资助金额:$32.62万
-
财政年份:2013
-
负责人:TIMOTHY N BULLOCK
-
依托单位:
BLIMP-1 mediated regulation of CD8+ TIL
-
批准号:8990555
-
项目类别:
-
资助金额:$7.27万
-
财政年份:2013
-
负责人:TIMOTHY N BULLOCK
-
依托单位:
Strategies for Therapeutic Vaccination Against KSHV
-
批准号:7852170
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2009
-
负责人:TIMOTHY N BULLOCK
-
依托单位:
Strategies for Therapeutic Vaccination Against KSHV
-
批准号:7943993
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2009
-
负责人:TIMOTHY N BULLOCK
-
依托单位:
CD70 Mediated Costimulation of T Cell Responses
-
批准号:7622810
-
项目类别:
-
资助金额:$25.41万
-
财政年份:2008
-
负责人:TIMOTHY N BULLOCK
-
依托单位:
CD70 mediated costimulation of T cell responses
-
批准号:7092641
-
项目类别:
-
资助金额:$23.37万
-
财政年份:2005
-
负责人:TIMOTHY N BULLOCK
-
依托单位:
CD70 mediated costimulation of T cell responses
-
批准号:7231012
-
项目类别:
-
资助金额:$24.74万
-
财政年份:2005
-
负责人:TIMOTHY N BULLOCK
-
依托单位:
CD70 mediated costimulation of T cell responses
-
批准号:6957042
-
项目类别:
-
资助金额:$24.1万
-
财政年份:2005
-
负责人:TIMOTHY N BULLOCK
-
依托单位:
The role of CD4+ T cells in melanoma immunotherapy
-
批准号:7070020
-
项目类别:
-
资助金额:$13.71万
-
财政年份:2002
-
负责人:TIMOTHY N BULLOCK
-
依托单位:
The role of CD4+ T cells in melanoma immunotherapy
-
批准号:6623110
-
项目类别:
-
资助金额:$13.0万
-
财政年份:2002
-
负责人:TIMOTHY N BULLOCK
-
依托单位:
The role of CD4+ T cells in melanoma immunotherapy
-
批准号:6463179
-
项目类别:
-
资助金额:$10.62万
-
财政年份:2002
-
负责人:TIMOTHY N BULLOCK
-
依托单位:
海外基金